Early clinical outcomes and routine management of patients with non-ST-segment elevation myocardial infarction: a
1Division of Cardiovascular Medicine, University of Massachusetts Medical School, 55 Lake Ave N, Worcester, MA 01655, USA. beckerr@ummhc.org
Insights
Management of non-ST-segment elevation myocardial infarction (NSTEMI) needs improvement, as pharmacologic therapy use was suboptimal, especially in high-risk patients. Invasive procedures were common but varied by severity, highlighting a need for guideline adherence.
Area of Science:
- Cardiology
- Clinical Medicine
- Public Health
Background:
- Non-ST-segment elevation myocardial infarction (NSTEMI) accounts for a growing proportion of acute ischemic chest pain hospitalizations.
- Key demographic, management, and outcome data for NSTEMI patients remain incompletely defined.
Purpose of the Study:
- To define demographic features, hospital management, and short-term outcomes in a large NSTEMI patient cohort.
- To assess the utilization of pharmacologic therapies and invasive procedures in NSTEMI care.
Main Methods:
- Retrospective analysis of 183,113 NSTEMI patients from the National Registry of Myocardial Infarction.
- Classification of patients into major, intermediate, and minor clinical event severity categories using a validated model.
Main Results:
- Suboptimal use of recommended pharmacologic therapies (aspirin, beta-blockers) was observed, particularly in major severity NSTEMI cases.
- Coronary angiography and revascularization were frequent (>60%), but more common in minor than major severity patients.
Conclusions:
- NSTEMI patients represent a heterogeneous group with distinct characteristics linked to early outcomes like death.
- Continued nationwide efforts are crucial to optimize pharmacologic therapy and align invasive procedures with established NSTEMI guidelines.
Background:
Myocardial infarction (MI) in the absence of electrocardiographic ST-segment elevation or new bundle branch block is the cause of hospitalization for a large and steadily increasing proportion of patients with acute ischemic chest pain. Despite its prevalence, the common demographic features, current hospital-based management, and short-term clinical outcome among patients with non-ST-segment elevation MI remain poorly defined.
Methods:
A total of 183 113 patients with non-ST-segment elevation MI were identified in the National Registry of Myocardial Infarction database. Using a validated model, 43 928 patients (24.0%) were retrospectively placed in major, 34 917 (19.1%) in intermediate, and 104 268 (56.9%) in minor severity clinical event categories that included hospital death, recurrent myocardial ischemia, and nonfatal recurrent MI.
Results:
The administration of widely available and universally recommended pharmacologic therapies, including aspirin and beta-adrenergic blocking agents, was suboptimal, particularly among patients with major severity clinical events. In contrast, coronary angiography and mechanical revascularization procedures were commonplace (>60% of all patients) and most frequently performed in patients within the minor (compared with the major) severity clinical event category (58.2% and 42.7%, respectively).
Conclusions:
Patients with non-ST-segment elevation MI are a heterogeneous population, with readily identifiable demographic characteristics and clinical features associated with important early outcomes, including death. Nationwide efforts directed toward maximizing pharmacologic therapy utilization and the performance of invasive procedures according to established guidelines must continue.
Related Concept Videos
01:28Acute Coronary Syndrome IV: Interprofessional Care
01:22Myocarditis IV: Nursing Management
01:30Acute Coronary Syndrome I: Introduction
01:20Angina V: Nursing Management
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
01:26Acute Coronary Syndrome V: Nursing Management